Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A team of researchers have created a simpler version of electronic wearable devices that can be used for physiological monitoring and alert a user of any health risks in real time.
Apple has teamed up with Zimmer Bioment to track patients who have undergone hip and knee replacement surgeries—two of the most common surgeries in the nation.
Early results from a study revealed the Dot (Dynamic Optimal Timing) mobile application is an effective tool for helping women plan or prevent pregnancies.
Apple will donate 1,000 of its watches to help the University of North Carolina School of Medicine researchers monitor how well the device tracks eating disorders, according to a report by CNBC.
Medicare Advantage plans—which cover about one-third of all Medicare beneficiaries—are improperly denying medical claims to patients and physicians, according to The New York Times.
Many Americans want a different relationship with their doctors that goes beyond treating sickness, according to a recent survey from Samueli Integrative Health Programs.
The FDA granted market clearance to Belgian company Qompium for its FibriCheck phone app, which is expected to launch in the United States market in 2019.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.